Global Exosome Diagnostic and Therapeutics Market Research Report 2024

Report ID: 1977907 | Published Date: Jan 2025 | No. of Page: 85 | Base Year: 2024 | Rating: 4.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Exosome Diagnostic and Therapeutics Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Instrument
        1.2.3 Software
        1.2.4 Reagents and Kits
    1.3 Market by Application
        1.3.1 Global Exosome Diagnostic and Therapeutics Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Cancer Institutes
        1.3.4 Diagnostic Centres
        1.3.5 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Exosome Diagnostic and Therapeutics Market Perspective (2017-2028)
    2.2 Exosome Diagnostic and Therapeutics Growth Trends by Region
        2.2.1 Exosome Diagnostic and Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Exosome Diagnostic and Therapeutics Historic Market Size by Region (2017-2022)
        2.2.3 Exosome Diagnostic and Therapeutics Forecasted Market Size by Region (2023-2028)
    2.3 Exosome Diagnostic and Therapeutics Market Dynamics
        2.3.1 Exosome Diagnostic and Therapeutics Industry Trends
        2.3.2 Exosome Diagnostic and Therapeutics Market Drivers
        2.3.3 Exosome Diagnostic and Therapeutics Market Challenges
        2.3.4 Exosome Diagnostic and Therapeutics Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Exosome Diagnostic and Therapeutics Players by Revenue
        3.1.1 Global Top Exosome Diagnostic and Therapeutics Players by Revenue (2017-2022)
        3.1.2 Global Exosome Diagnostic and Therapeutics Revenue Market Share by Players (2017-2022)
    3.2 Global Exosome Diagnostic and Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Exosome Diagnostic and Therapeutics Revenue
    3.4 Global Exosome Diagnostic and Therapeutics Market Concentration Ratio
        3.4.1 Global Exosome Diagnostic and Therapeutics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Exosome Diagnostic and Therapeutics Revenue in 2021
    3.5 Exosome Diagnostic and Therapeutics Key Players Head office and Area Served
    3.6 Key Players Exosome Diagnostic and Therapeutics Product Solution and Service
    3.7 Date of Enter into Exosome Diagnostic and Therapeutics Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Exosome Diagnostic and Therapeutics Breakdown Data by Type
    4.1 Global Exosome Diagnostic and Therapeutics Historic Market Size by Type (2017-2022)
    4.2 Global Exosome Diagnostic and Therapeutics Forecasted Market Size by Type (2023-2028)
5 Exosome Diagnostic and Therapeutics Breakdown Data by Application
    5.1 Global Exosome Diagnostic and Therapeutics Historic Market Size by Application (2017-2022)
    5.2 Global Exosome Diagnostic and Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Exosome Diagnostic and Therapeutics Market Size (2017-2028)
    6.2 North America Exosome Diagnostic and Therapeutics Market Size by Country (2017-2022)
    6.3 North America Exosome Diagnostic and Therapeutics Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Exosome Diagnostic and Therapeutics Market Size (2017-2028)
    7.2 Europe Exosome Diagnostic and Therapeutics Market Size by Country (2017-2022)
    7.3 Europe Exosome Diagnostic and Therapeutics Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Exosome Diagnostic and Therapeutics Market Size (2017-2028)
    8.2 Asia-Pacific Exosome Diagnostic and Therapeutics Market Size by Country (2017-2022)
    8.3 Asia-Pacific Exosome Diagnostic and Therapeutics Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Exosome Diagnostic and Therapeutics Market Size (2017-2028)
    9.2 Latin America Exosome Diagnostic and Therapeutics Market Size by Country (2017-2022)
    9.3 Latin America Exosome Diagnostic and Therapeutics Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Exosome Diagnostic and Therapeutics Market Size (2017-2028)
    10.2 Middle East & Africa Exosome Diagnostic and Therapeutics Market Size by Country (2017-2022)
    10.3 Middle East & Africa Exosome Diagnostic and Therapeutics Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Thermo Fisher
        11.1.1 Thermo Fisher Company Detail
        11.1.2 Thermo Fisher Business Overview
        11.1.3 Thermo Fisher Exosome Diagnostic and Therapeutics Introduction
        11.1.4 Thermo Fisher Revenue in Exosome Diagnostic and Therapeutics Business (2017-2022)
        11.1.5 Thermo Fisher Recent Development
    11.2 NanoSomix
        11.2.1 NanoSomix Company Detail
        11.2.2 NanoSomix Business Overview
        11.2.3 NanoSomix Exosome Diagnostic and Therapeutics Introduction
        11.2.4 NanoSomix Revenue in Exosome Diagnostic and Therapeutics Business (2017-2022)
        11.2.5 NanoSomix Recent Development
    11.3 NX PHARMAGEN
        11.3.1 NX PHARMAGEN Company Detail
        11.3.2 NX PHARMAGEN Business Overview
        11.3.3 NX PHARMAGEN Exosome Diagnostic and Therapeutics Introduction
        11.3.4 NX PHARMAGEN Revenue in Exosome Diagnostic and Therapeutics Business (2017-2022)
        11.3.5 NX PHARMAGEN Recent Development
    11.4 Malvern
        11.4.1 Malvern Company Detail
        11.4.2 Malvern Business Overview
        11.4.3 Malvern Exosome Diagnostic and Therapeutics Introduction
        11.4.4 Malvern Revenue in Exosome Diagnostic and Therapeutics Business (2017-2022)
        11.4.5 Malvern Recent Development
    11.5 Capricor
        11.5.1 Capricor Company Detail
        11.5.2 Capricor Business Overview
        11.5.3 Capricor Exosome Diagnostic and Therapeutics Introduction
        11.5.4 Capricor Revenue in Exosome Diagnostic and Therapeutics Business (2017-2022)
        11.5.5 Capricor Recent Development
    11.6 Exosome
        11.6.1 Exosome Company Detail
        11.6.2 Exosome Business Overview
        11.6.3 Exosome Exosome Diagnostic and Therapeutics Introduction
        11.6.4 Exosome Revenue in Exosome Diagnostic and Therapeutics Business (2017-2022)
        11.6.5 Exosome Recent Development
    11.7 Exiqon
        11.7.1 Exiqon Company Detail
        11.7.2 Exiqon Business Overview
        11.7.3 Exiqon Exosome Diagnostic and Therapeutics Introduction
        11.7.4 Exiqon Revenue in Exosome Diagnostic and Therapeutics Business (2017-2022)
        11.7.5 Exiqon Recent Development
    11.8 System Biosciences
        11.8.1 System Biosciences Company Detail
        11.8.2 System Biosciences Business Overview
        11.8.3 System Biosciences Exosome Diagnostic and Therapeutics Introduction
        11.8.4 System Biosciences Revenue in Exosome Diagnostic and Therapeutics Business (2017-2022)
        11.8.5 System Biosciences Recent Development
    11.9 Aegle
        11.9.1 Aegle Company Detail
        11.9.2 Aegle Business Overview
        11.9.3 Aegle Exosome Diagnostic and Therapeutics Introduction
        11.9.4 Aegle Revenue in Exosome Diagnostic and Therapeutics Business (2017-2022)
        11.9.5 Aegle Recent Development
    11.10 AMS
        11.10.1 AMS Company Detail
        11.10.2 AMS Business Overview
        11.10.3 AMS Exosome Diagnostic and Therapeutics Introduction
        11.10.4 AMS Revenue in Exosome Diagnostic and Therapeutics Business (2017-2022)
        11.10.5 AMS Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Exosome Diagnostic and Therapeutics Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Instrument
    Table 3. Key Players of Software
    Table 4. Key Players of Reagents and Kits
    Table 5. Global Exosome Diagnostic and Therapeutics Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Exosome Diagnostic and Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Exosome Diagnostic and Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 8. Global Exosome Diagnostic and Therapeutics Market Share by Region (2017-2022)
    Table 9. Global Exosome Diagnostic and Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 10. Global Exosome Diagnostic and Therapeutics Market Share by Region (2023-2028)
    Table 11. Exosome Diagnostic and Therapeutics Market Trends
    Table 12. Exosome Diagnostic and Therapeutics Market Drivers
    Table 13. Exosome Diagnostic and Therapeutics Market Challenges
    Table 14. Exosome Diagnostic and Therapeutics Market Restraints
    Table 15. Global Exosome Diagnostic and Therapeutics Revenue by Players (2017-2022) & (US$ Million)
    Table 16. Global Exosome Diagnostic and Therapeutics Market Share by Players (2017-2022)
    Table 17. Global Top Exosome Diagnostic and Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Exosome Diagnostic and Therapeutics as of 2021)
    Table 18. Ranking of Global Top Exosome Diagnostic and Therapeutics Companies by Revenue (US$ Million) in 2021
    Table 19. Global 5 Largest Players Market Share by Exosome Diagnostic and Therapeutics Revenue (CR5 and HHI) & (2017-2022)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Exosome Diagnostic and Therapeutics Product Solution and Service
    Table 22. Date of Enter into Exosome Diagnostic and Therapeutics Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Exosome Diagnostic and Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 25. Global Exosome Diagnostic and Therapeutics Revenue Market Share by Type (2017-2022)
    Table 26. Global Exosome Diagnostic and Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 27. Global Exosome Diagnostic and Therapeutics Revenue Market Share by Type (2023-2028)
    Table 28. Global Exosome Diagnostic and Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 29. Global Exosome Diagnostic and Therapeutics Revenue Market Share by Application (2017-2022)
    Table 30. Global Exosome Diagnostic and Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 31. Global Exosome Diagnostic and Therapeutics Revenue Market Share by Application (2023-2028)
    Table 32. North America Exosome Diagnostic and Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 33. North America Exosome Diagnostic and Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 34. Europe Exosome Diagnostic and Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 35. Europe Exosome Diagnostic and Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 36. Asia-Pacific Exosome Diagnostic and Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 37. Asia-Pacific Exosome Diagnostic and Therapeutics Market Size by Region (2023-2028) & (US$ Million)
    Table 38. Latin America Exosome Diagnostic and Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 39. Latin America Exosome Diagnostic and Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 40. Middle East & Africa Exosome Diagnostic and Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 41. Middle East & Africa Exosome Diagnostic and Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 42. Thermo Fisher Company Detail
    Table 43. Thermo Fisher Business Overview
    Table 44. Thermo Fisher Exosome Diagnostic and Therapeutics Product
    Table 45. Thermo Fisher Revenue in Exosome Diagnostic and Therapeutics Business (2017-2022) & (US$ Million)
    Table 46. Thermo Fisher Recent Development
    Table 47. NanoSomix Company Detail
    Table 48. NanoSomix Business Overview
    Table 49. NanoSomix Exosome Diagnostic and Therapeutics Product
    Table 50. NanoSomix Revenue in Exosome Diagnostic and Therapeutics Business (2017-2022) & (US$ Million)
    Table 51. NanoSomix Recent Development
    Table 52. NX PHARMAGEN Company Detail
    Table 53. NX PHARMAGEN Business Overview
    Table 54. NX PHARMAGEN Exosome Diagnostic and Therapeutics Product
    Table 55. NX PHARMAGEN Revenue in Exosome Diagnostic and Therapeutics Business (2017-2022) & (US$ Million)
    Table 56. NX PHARMAGEN Recent Development
    Table 57. Malvern Company Detail
    Table 58. Malvern Business Overview
    Table 59. Malvern Exosome Diagnostic and Therapeutics Product
    Table 60. Malvern Revenue in Exosome Diagnostic and Therapeutics Business (2017-2022) & (US$ Million)
    Table 61. Malvern Recent Development
    Table 62. Capricor Company Detail
    Table 63. Capricor Business Overview
    Table 64. Capricor Exosome Diagnostic and Therapeutics Product
    Table 65. Capricor Revenue in Exosome Diagnostic and Therapeutics Business (2017-2022) & (US$ Million)
    Table 66. Capricor Recent Development
    Table 67. Exosome Company Detail
    Table 68. Exosome Business Overview
    Table 69. Exosome Exosome Diagnostic and Therapeutics Product
    Table 70. Exosome Revenue in Exosome Diagnostic and Therapeutics Business (2017-2022) & (US$ Million)
    Table 71. Exosome Recent Development
    Table 72. Exiqon Company Detail
    Table 73. Exiqon Business Overview
    Table 74. Exiqon Exosome Diagnostic and Therapeutics Product
    Table 75. Exiqon Revenue in Exosome Diagnostic and Therapeutics Business (2017-2022) & (US$ Million)
    Table 76. Exiqon Recent Development
    Table 77. System Biosciences Company Detail
    Table 78. System Biosciences Business Overview
    Table 79. System Biosciences Exosome Diagnostic and Therapeutics Product
    Table 80. System Biosciences Revenue in Exosome Diagnostic and Therapeutics Business (2017-2022) & (US$ Million)
    Table 81. System Biosciences Recent Development
    Table 82. Aegle Company Detail
    Table 83. Aegle Business Overview
    Table 84. Aegle Exosome Diagnostic and Therapeutics Product
    Table 85. Aegle Revenue in Exosome Diagnostic and Therapeutics Business (2017-2022) & (US$ Million)
    Table 86. Aegle Recent Development
    Table 87. AMS Company Detail
    Table 88. AMS Business Overview
    Table 89. AMS Exosome Diagnostic and Therapeutics Product
    Table 90. AMS Revenue in Exosome Diagnostic and Therapeutics Business (2017-2022) & (US$ Million)
    Table 91. AMS Recent Development
    Table 92. Research Programs/Design for This Report
    Table 93. Key Data Information from Secondary Sources
    Table 94. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Exosome Diagnostic and Therapeutics Market Share by Type: 2021 VS 2028
    Figure 2. Instrument Features
    Figure 3. Software Features
    Figure 4. Reagents and Kits Features
    Figure 5. Global Exosome Diagnostic and Therapeutics Market Share by Application in 2021 & 2028
    Figure 6. Hospitals Case Studies
    Figure 7. Cancer Institutes Case Studies
    Figure 8. Diagnostic Centres Case Studies
    Figure 9. Others Case Studies
    Figure 10. Exosome Diagnostic and Therapeutics Report Years Considered
    Figure 11. Global Exosome Diagnostic and Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 12. Global Exosome Diagnostic and Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Exosome Diagnostic and Therapeutics Market Share by Region: 2021 VS 2028
    Figure 14. Global Exosome Diagnostic and Therapeutics Market Share by Players in 2021
    Figure 15. Global Top Exosome Diagnostic and Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Exosome Diagnostic and Therapeutics as of 2021)
    Figure 16. The Top 10 and 5 Players Market Share by Exosome Diagnostic and Therapeutics Revenue in 2021
    Figure 17. North America Exosome Diagnostic and Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. North America Exosome Diagnostic and Therapeutics Market Share by Country (2017-2028)
    Figure 19. United States Exosome Diagnostic and Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Canada Exosome Diagnostic and Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Exosome Diagnostic and Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Exosome Diagnostic and Therapeutics Market Share by Country (2017-2028)
    Figure 23. Germany Exosome Diagnostic and Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. France Exosome Diagnostic and Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. U.K. Exosome Diagnostic and Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Italy Exosome Diagnostic and Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Russia Exosome Diagnostic and Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Nordic Countries Exosome Diagnostic and Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Asia-Pacific Exosome Diagnostic and Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Asia-Pacific Exosome Diagnostic and Therapeutics Market Share by Region (2017-2028)
    Figure 31. China Exosome Diagnostic and Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Japan Exosome Diagnostic and Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. South Korea Exosome Diagnostic and Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Southeast Asia Exosome Diagnostic and Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. India Exosome Diagnostic and Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Australia Exosome Diagnostic and Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Latin America Exosome Diagnostic and Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Latin America Exosome Diagnostic and Therapeutics Market Share by Country (2017-2028)
    Figure 39. Mexico Exosome Diagnostic and Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Brazil Exosome Diagnostic and Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Middle East & Africa Exosome Diagnostic and Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Middle East & Africa Exosome Diagnostic and Therapeutics Market Share by Country (2017-2028)
    Figure 43. Turkey Exosome Diagnostic and Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Saudi Arabia Exosome Diagnostic and Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Thermo Fisher Revenue Growth Rate in Exosome Diagnostic and Therapeutics Business (2017-2022)
    Figure 46. NanoSomix Revenue Growth Rate in Exosome Diagnostic and Therapeutics Business (2017-2022)
    Figure 47. NX PHARMAGEN Revenue Growth Rate in Exosome Diagnostic and Therapeutics Business (2017-2022)
    Figure 48. Malvern Revenue Growth Rate in Exosome Diagnostic and Therapeutics Business (2017-2022)
    Figure 49. Capricor Revenue Growth Rate in Exosome Diagnostic and Therapeutics Business (2017-2022)
    Figure 50. Exosome Revenue Growth Rate in Exosome Diagnostic and Therapeutics Business (2017-2022)
    Figure 51. Exiqon Revenue Growth Rate in Exosome Diagnostic and Therapeutics Business (2017-2022)
    Figure 52. System Biosciences Revenue Growth Rate in Exosome Diagnostic and Therapeutics Business (2017-2022)
    Figure 53. Aegle Revenue Growth Rate in Exosome Diagnostic and Therapeutics Business (2017-2022)
    Figure 54. AMS Revenue Growth Rate in Exosome Diagnostic and Therapeutics Business (2017-2022)
    Figure 55. Bottom-up and Top-down Approaches for This Report
    Figure 56. Data Triangulation
    Figure 57. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Thermo Fisher
NanoSomix
NX PHARMAGEN
Malvern
Capricor
Exosome
Exiqon
System Biosciences
Aegle
AMS
Frequently Asked Questions
Exosome Diagnostic and Therapeutics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Exosome Diagnostic and Therapeutics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Exosome Diagnostic and Therapeutics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Farm Animal Drugs

Farm Animal Drugs market is segmented by players, region (country), by Type and by Application. P ... Read More

Feed Phytogenic

The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More